Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Tell the agent you have injectable medication before your bag is screened
The medication works quietly in the background, activating GIP and GLP-1 receptors, slowing gastric emptying, enhancing insulin secretion, and suppressing glucagon
Weight loss naturally reduces total body water content, improved glycemic control in diabetic patients may reduce osmotic diuresis from glucosuria, and gastrointestinal side effects can temporarily affect hydration status
Safety Considerations & Screening Protocols Both Medvi and compounded-GLP-1 pathways require baseline screening for contraindications: personal or family history of medullary thyroid carcinoma (MTC), multiple endocrine neoplasia type 2 (MEN2), severe pancreatitis, or diabetic retinopathy
US$ 21.84
US$ 20.58
US$ 23.83
